With the crisis deepening and strengthening due to European situation, Currency depreciation, Inflation and Political instability, India's Stock market doesn't seems to be the right place to park money and multiply. But not all sectors will be suffering due to the current situation. Pharmaceuticals sector is a no-stop train, although it gets sluggish due to global factors. Rupee depreciating will boost the sector as 40-45% is exported. Primarily, Lupin in Pharma looks strong without too many hiccups compared to it's counterparts in the sector. Also, Apollo Hospital after a GDR with Mauritus based Healthcare looks strong and promising. Sun Pharma looks in a better position as they have zero hedging policy against dollar. Ranbaxy after the FDA settlement needs to cover up losses.
